Treace Medical Concepts Inc (TMCI)
5.75
+0.31
(+5.70%)
USD |
NASDAQ |
Nov 05, 16:00
6.70
+0.95
(+16.52%)
After-Hours: 20:00
Treace Medical Concepts Cash from Investing (Quarterly): 22.43M for June 30, 2024
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 22.43M |
| March 31, 2024 | 3.758M |
| December 31, 2023 | 5.007M |
| September 30, 2023 | 4.597M |
| June 30, 2023 | -10.42M |
| March 31, 2023 | -80.48M |
| December 31, 2022 | -64.01M |
| September 30, 2022 | -5.857M |
| June 30, 2022 | -5.168M |
| Date | Value |
|---|---|
| March 31, 2022 | -1.481M |
| December 31, 2021 | -0.90M |
| September 30, 2021 | -0.939M |
| June 30, 2021 | -0.67M |
| March 31, 2021 | -0.196M |
| December 31, 2020 | -0.088M |
| September 30, 2020 | -0.058M |
| June 30, 2020 | -0.249M |
| March 31, 2020 | -0.674M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-80.48M
Minimum
Mar 2023
22.43M
Maximum
Jun 2024
-7.522M
Average
-0.672M
Median
Cash from Investing (Quarterly) Benchmarks
| Stryker Corp | -2.172B |
| Perspective Therapeutics Inc | -3.295M |
| Retractable Technologies Inc | -0.3223M |
| Xtant Medical Holdings Inc | -0.48M |
| Catheter Precision Inc | -0.045M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -13.90M |
| Cash from Financing (Quarterly) | 0.311M |
| Free Cash Flow | -41.50M |
| Free Cash Flow Per Share (Quarterly) | -0.2517 |
| Free Cash Flow to Equity (Quarterly) | -15.70M |
| Free Cash Flow Yield | -11.68% |